[The statement of Polish Gynecological Society experts about human papillomavirus (HPV) vaccine use to prevent cervical cancer (state of the art from the 19th of September 2009)].
Kotarski
Jan
J
Klinika I Katedra i Klinika Ginekologii Onkologicznej i Ginekologii AM w Lublinie.
Basta
Antoni
A
Debski
Romuald
R
Karowicz-Bilińska
Agata
A
Kedzia
Witold
W
Niemiec
Tomasz
T
Nowak-Markwitz
Ewa
E
Olejek
Anita
A
Poreba
Ryszard
R
Spaezyński
Marek
M
Wysocki
Jacek
J
D003226:Congresses as Topic; D005260:Female; D006176:Gynecology / Q000592:standards; D006801:Humans; D007318:Inservice Training / Q000592:standards; D008297:Male; D009313:National Health Programs / Q000592:standards; D009774:Obstetrics / Q000592:standards; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D011044:Poland; D011322:Primary Prevention / Q000592:standards; D011372:Progestins / Q000592:standards; D011785:Quality Assurance, Health Care / Q000592:standards; D012955:Societies, Medical / Q000592:standards; D014412:Tumor Virus Infections / Q000517:prevention & control*; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology
D053918:Papillomavirus Vaccines; D011372:Progestins